Erasmus Summer Programme Courses

Take a look at all the courses in the Erasmus Summer Programme, and find the course right for you.

View all ESP courses

Pharmaco-epidemiology [ESP21]

Course highlights

EC points


Start date

12 August 2019

End date

16 August 2019

Course days

Monday to Friday (5 mornings)

Course time

From 8:45 till 11:45


Prof. Bruno Stricker

Course fee

€ 470


Erasmus MC, Rotterdam NL




Principles of Research in Medicine and Epidemiology or equivalent knowledge.


  • Pharmaco Epidemiology

Course Materials

Online, download instructions will be sent in August by e-mail.
A laptop is recommended.

Apply for this course?

Design your programme

Try using our Programme Configurator to design and plan your own programme.



Itai Magodoro


The professors - who are at the cutting edge in their respective fields - bring science to life!

Read the full story

Detailed information about this course:


Faculty: Prof. Bruno Stricker, PhD

Pharmaco-epidemiology pertains to the study of the use and of the effects of drugs. It links clinical pharmacology and epidemiology. This course provides, at an intermediate level, the theoretical basis for studying the intended effects as well as the adverse effects of drugs used in humans. The course will mainly focus on drug research after marketing, including post marketing surveillance and drug risk assessment.

This course is intended for those who already followed introductory courses in study design, data-analysis and principles of research in medicine.

Teaching methods

Plenary interactive teaching with real-life examples and exercises


  • To know more about study designs in pharmaco-epidemiology;
  • To know how to address exposure as a determinant;
  • To know more about drug-specific bias and confounding.

Participant profile

The course is meant for those for whom drug safety and effectiveness research is a part of their current or future professional career. Examples are: clinical epidemiologists, healthcare workers, regulators, and doctors in the pharmaceutical industry.